首页> 外国专利> CANCER IMMUNOTHERAPY USING ALLOSTIMULATED CELLS IN A MULTIPLE SEQUENTIAL IMPLANTATION STRATEGY

CANCER IMMUNOTHERAPY USING ALLOSTIMULATED CELLS IN A MULTIPLE SEQUENTIAL IMPLANTATION STRATEGY

机译:在多种顺序植入策略中使用同种优化的细胞进行癌症免疫治疗

摘要

This invention provides medicaments and methods for managing cancer using donor cells that are alloactivated in culture. Alloactivated cells are implanted into the bed of a solid tumor and initiate a response by the host against the tumor. Subsequently, alloactivated cells are implanted into the bed of a solid tumor a second time. The two implants work synergistically to confer remarkable benefit to the treated subject, both in terms of management of the cancer and the development of an anti-cancer immune response. The beneficial effects may include regression of the tumor and extended survival. Removal of any residual tumor after the second implant facilitates ongoing resistance to tumor regrowth or metastasis.
机译:本发明提供了使用在培养物中被同种激活的供体细胞来控制癌症的药物和方法。同种异体激活的细胞被植入实体瘤床中,并由宿主发起对肿瘤的反应。随后,第二次将同种异体激活的细胞植入实体瘤床中。两种植入物协同作用,以在治疗癌症和发展抗癌免疫应答方面为被治疗的受试者带来显着的益处。有益效果可能包括肿瘤消退和延长生存期。在第二次植入后去除任何残留的肿瘤有利于持续抵抗肿瘤的再生或转移。

著录项

  • 公开/公告号EP1037643A1

    专利类型

  • 公开/公告日2000-09-27

    原文格式PDF

  • 申请/专利权人 MEYER PHARMACEUTICALS LLC;

    申请/专利号EP19980949603

  • 发明设计人 HISERODT JOHN C.;

    申请日1998-09-29

  • 分类号A61K35/14;

  • 国家 EP

  • 入库时间 2022-08-22 01:46:48

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号